Become an Osteosarcoma Advocate
This Movement Needs Everyone
Osteosarcoma Statistics
Osteosarcoma is the most common childhood bone cancer.
No new treatments have been approved for osteosarcoma patients in 40 years.
1 in 3 children with osteosarcoma will not survive.
How You Can Help
Start a Facebook Fundraiser
Sign Up for the Newsletter
Share Your Story With Us
Make a Donation to Find a Cure
What We Do
Our Strategy
Globally estimated, there are over 26,000 new cases of osteosarcoma diagnosed each year, with 1,000 being diagnosed in the United States, but treatment options haven’t advanced in 40 years. To find a cure for osteosarcoma, we have to collaborate, innovate, and translate around the most promising science.
Our Mission
The mission of the Osteosarcoma Institute is to dramatically increase treatment options and survival rates in osteosarcoma patients through identifying and funding the most promising and breakthrough osteosarcoma clinical trials and science.
Start Your Own Partnering for Progress Fund
To take a bigger step in osteosarcoma advocacy, you can create your own osteosarcoma science fund with our support and infrastructure. Through a Partnering for Progress fund, we help you determine a research study or trial to support, and we handle many of the logistics, allowing you to focus on reaching out to friends and family to make a difference for osteosarcoma patients everywhere. If you are interested in learning more about Partnering for Progress, please email giving@osinst.org and our Director of Development, Vanessa (Peterson) Montemayor, will be in touch.
Lizzy’s Osteosarcoma Science Fund
In 2020, the Osteosarcoma Institute partnered with Lizzy’s Walk of Faith Foundation to establish Lizzy’s Osteosarcoma Science Fund at the OSI. Together, we have raised more than $150,000 (as of April 2025) in honor of Lizzy Wampler. Lizzy’s parents and the founders of LWOF Foundation, Jennifer and John Wampler, have chosen to support the OSI’s broader research efforts to address the most urgent needs in osteosarcoma treatment.
#TeamIzzy’s Osteosarcoma Science Fund
In 2021, the Osteosarcoma Institute joined forces with osteosarcoma patient, Izzy Martin, and her family to start a fund in her name. Together, we have raised more than $760,000 (as of April 2025), which will be applied to a breakthrough clinical trial or study in osteosarcoma this year. Izzy’s mom, Christine, shares, “Izzy’s wish is that one day, no child will have to go through what she did.”
The Rally Foundation
In 2024, The Rally Foundation for Childhood Cancer Research partnered with the Osteosarcoma Institute to co-fund Dr. Jason Yustein’s immunotherapy study for high-risk osteosarcoma at Emory University. The Rally Foundation is dedicated to empowering volunteers to raise awareness and funds to find better treatments, and ultimately cures, for all pediatric cancers.
Hartz Family Osteosarcoma Fund
In 2022, Ingrid and David Hartz established the Hartz Family Fund at the OSI in memory of their teenage son, Miles. The Hartz Fund has raised more than $450,000 (as of March 2025) for osteosarcoma research conducted by Dr. Richard Gorlick at MD Anderson Cancer Center as well as a study by Dr. Poul Sorensen at the University of British Columbia. They are motivated to help support the most promising clinical trials and science to fight osteosarcoma. Support their fight by making a donation to their fund today.
Our Impact
$5,500,525
to Translational Studies
$1,480,000
to Clinical Trials
$1,120,000
to Correlative Science
$521,329
to Discretionary Grants
Read Survivor Stories
Osteosarcoma Diagnosis Brings New Perspective on Life
When a cancer diagnosis upended his life, Talgat shifted his perspective to make the most out of life, living each day to the fullest.
Finding the Best Life-Saving Cancer Care for Their Daughter
Trusting their gut helped Jessica and Stephen Alwan get the life-saving care their daughter desperately needed.
Multiple Cancer Diagnoses Spark a Career in Cancer Research
When Suresh Madheswaran, PhD, was diagnosed with multiple cancers, he took it on himself to advance the research.
Institutional Collaborators
